two-year evolut low risk trial data shows “very favourable outcomes” for tavi compared with savr
Published 3 years ago • 88 plays • Length 5:17Download video MP4
Download video MP3
Similar videos
-
3:47
acc 23: tavr in low-risk aortic stenosis patients: 3-year results from the evolut low risk trial
-
1:09:12
tavi, savr, pci and low risk patients
-
7:19
evolut pro: a legacy of superior outcomes - jeffrey popma, md
-
28:16
episode 19 | transcatheter aortic valve replacement (tavr) vs surgical aortic valve replacement
-
7:09
tct 2021: partner 3: tavr is cost effective compared with savr for low-risk patients
-
43:49
transcatheter aortic valve replacement: will surgical avr disappear? (michael reardon, md)
-
52:20
savr vs. tavr patient webinar: what should patients know?
-
4:00
transcatheter aortic valve implantation (tavi)
-
24:40
tavi: transcatheter aortic valve implamentation presentation - christopher glover, md
-
23:14
dr david muller: transcatheter aortic valve implantation in 2015
-
24:34
transcatheter valve replacement (tavr) and savr-update on outcome
-
1:14:01
the future of savr: the big debate
-
27:00
workshop 2 aortic stenosis in the elderly: tavi or surgery
-
0:15
how an edwards tavr valve is deployed to treat aortic stenosis #tavr #cardiology
-
1:02:31
summer series: savr vs. tavr: controversial cases and insights from the experts
-
0:42
transcatheter aortic valve implantation procedure (tavi)
-
7:30
europcr 21: tavr for bav stenosis in low surgical risk patients
-
48:06
structural heart :tavr with a 26mm evolut-fx valve in a very small patient
-
58:21
optimising immediate and long-term outcomes after tavi - pcr london valves 2022